ArticleUrologia internationalis2026
Clinical Presentation of Chronic Abacterial Prostatitis Shows No Association with TAS2R38 Taster Status.
Article in Urologia internationalis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a relatively common disease and shows an association with urogenital infections. Tuft cells in general have been identified at various entry points into the body (respiratory tract, gastrointestinal tract, and urogenital tract) and are seen as guardians against invading threats. Urethral tuft cells utilizing canonical taste transduction cascade to detect of microbial products and initiating reflex micturition and neurogenic inflammation as a protective mechanism in response. Impaired chemoreception of the T2R38 taste receptor predisposes individuals to upper respiratory tract infections. Therefore, it is very likely that impaired chemoreception has a comparable effect on bacterial urogenital infections, whereas nonbacterial urogenital infections should remain unaffected. The aim of this study was to investigate the influence of TAS2R38 receptor functionality, as measured by a taste test, on the clinical presentation of patients with chronic abacterial prostatitis type III.
methodsFrom 2016 to 2025, a total of 252 patients with diagnosed CP/CPPS received a comprehensive andrological work-up including a taste test for the functionality of the TAS2R38 receptor. Complete semen analysis was performed according to WHO 2021 recommendations including the determination of inflammatory parameters in the ejaculate as well as microbiological examination of first-void urine, post-prostate massage urine and ejaculate.
resultsThe proportion of tasters was 55.95%, while nontasters accounted for 44.05%. No significant differences could be found between tasters and nontasters with CP/CPPS with regard to symptom burden measured using questionnaires, various ejaculate parameters, prostate-specific antigen (PSA), and microbiological results. Only seminal elastase and serum C-reactive protein (CRP) levels showed a significant difference, but with higher values in the taster group, which, in view of our initial hypothesis, is more likely a statistical coincidence.
conclusionThe results of our studies show that the taste status of TAS2R38 in patients with chronic abacterial prostatitis type III had no association with symptom severity, the ejaculate parameters examined, or the serum levels of PSA and CRP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.